Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03972397 · ClinicalTrials.gov registry record · Phase 4
Intercostal Nerve Cryoablation for Postoperative Pain Management
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT03972397: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT03972397 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03972397, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the efficacy of intercostal nerve cryoablation on the magnitude and duration of postoperative pain control both in patients undergoing thoracoabdominal incisions for the descending or thoracoabdominal aortic aneurysm repair.
Primary Outcome
The NPS measures the intensity of pain. The total score ranges from 0 to 10, with 0 being no pain and 10 the highest pain.
Interventions
- DEVICE Intercostal Nerve Cryoablation
- DRUG Patient-controlled analgesia (PCA)
- DRUG Bupivacaine liposomal injectable suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2022-09-22 |
| Phase | Phase 4 |
What the finished NCT03972397 record still lists
NCT03972397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Intercostal Nerve Cryoablation is the first listed.
NCT03972397 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03972397 about?
NCT03972397 is a clinical study titled "Intercostal Nerve Cryoablation for Postoperative Pain Management". The purpose of the study is to assess the efficacy of intercostal nerve cryoablation on the magnitude and duration of postoperative pain control both in patients undergoing thoracoabdominal incisions for the descending or thoracoabdominal aortic aneurysm repair.
What is the current status of trial NCT03972397?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2019-07-15. Estimated completion is 2022-09-22.
What interventions are being tested in trial NCT03972397?
The interventions under investigation include: Intercostal Nerve Cryoablation (DEVICE), Patient-controlled analgesia (PCA) (DRUG), Bupivacaine liposomal injectable suspension (DRUG).
Who is sponsoring clinical trial NCT03972397?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03972397's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI